Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

       
Total article views   HTML views PDF downloads Totals
18,174 Dovepress* 13,170+ 1,660 14,830
PubMed Central* 5,004 1,190 6,194
Totals 18,174 2,850 21,024
*Since 21 March 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar